What is the comparative effectiveness of sodium-glucose cotransporter 2 inhibitors vs sulfonylureas associated with the risk of all-cause mortality among individuals using metformin for treatment of type 2 diabetes? The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.